8-K
Current Report
Spero Therapeutics, Inc. Filed Acc 0001193125-18-219722
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading d541709d8k.htm…